| Literature DB >> 31080796 |
Tamar B Wissing1,2, Valentina Bonito1,2, Eline E van Haaften1,2, Marina van Doeselaar1, Marieke M C P Brugmans3, Henk M Janssen4, Carlijn V C Bouten1,2, Anthal I P M Smits1,2.
Abstract
In situ tissue engineering is a technology in which non-cellular biomaterial scaffolds are implanted in order to induce local regeneration of replaced or damaged tissues. Degradable synthetic electrospun scaffolds are a versatile and promising class of biomaterials for various in situ tissue engineering applications, such as cardiovascular replacements. Functional in situ tissue regeneration depends on the balance between endogenous neo-tissue formation and scaffold degradation. Both these processes are driven by macrophages. Upon invasion into a scaffold, macrophages secrete reactive oxygen species (ROS) and hydrolytic enzymes, contributing to oxidative and enzymatic biomaterial degradation, respectively. This study aims to elucidate the effect of scaffold microarchitecture, i.e., μm-range fiber diameter and fiber alignment, on early macrophage-driven scaffold degradation. Electrospun poly-ε-caprolactone-bisurea (PCL-BU) scaffolds with either 2 or 6 μm (Ø) isotropic or anisotropic fibers were seeded with THP-1 derived human macrophages and cultured in vitro for 4 or 8 days. Our results revealed that macroph age-induced oxidative degradation in particular was dependent on scaffold microarchitecture, with the highest level of ROS-induced lipid peroxidation, NADPH oxidase gene expression and degradation in the 6 μm Ø anisotropic group. Whereas, biochemically polarized macrophages demonstrated a phenotype-specific degradative potential, the observed differences in macrophage degradative potential instigated by the scaffold microarchitecture could not be attributed to either distinct M1 or M2 polarization. This suggests that the scaffold microarchitecture uniquely affects macrophage-driven degradation. These findings emphasize the importance of considering the scaffold microarchitecture in the design of scaffolds for in situ tissue engineering applications and the tailoring of degradation kinetics thereof.Entities:
Keywords: electrospinning; enzymatic degradation; foreign body response; immunomodulation; in situ tissue engineering; macrophage polarization; oxidative degradation; reactive oxygen species
Year: 2019 PMID: 31080796 PMCID: PMC6497794 DOI: 10.3389/fbioe.2019.00087
Source DB: PubMed Journal: Front Bioeng Biotechnol ISSN: 2296-4185
Figure 1Schematic representation of the experimental outline and analyses. THP-1 derived macrophages were exposed to either scaffold microstructural stimuli (I) or biochemical stimuli (II) and analyzed for their degradation profile and phenotype. RPMI, Roswell Park Memorial Institute; 1640 medium; LPS, lipopolysaccharide; IFN-γ, interferon gamma; IL, interleukin; MDA, malondialdehyde; SEM, scanning electron microscopy; IHC, immunohistochemistry; ELISA, enzyme-linked immunosorbent assay; qPCR, quantitative polymerase chain reaction.
Electrospinning settings for the different scaffold microarchitectures.
| 2 | Isotropic | 10 | 24 | 20 | −2 | 100 |
| Anisotropic | 10 | 24 | 20 | −2 | 1,600 | |
| 6 | Isotropic | 40 | 16 | 20 | −1 | 100 |
| Anisotropic | 40 | 16 | 20 | −1 | 2,300 |
Primers for gene expression analysis.
| Monocyte chemoattractant protein 1 | MCP1 | FW: CAGCCAGATGCAATCAATGCC | |
| RV: TGGAATCCTGAACCCACTTCT | |||
| Cluster of differentiation 68 | CD68 | FW: CTACTGGCAGAGAGCACTGG | |
| RV: CCGCCATGTAGCTCAGGTAG | |||
| Chemokine (C-C motif) receptor 7 | CCR7 | FW: AAGCCTGGTTCCTCCCTATC | |
| RV: ATGGTCTTGAGCCTCTTGAAATA | |||
| Tumor necrosis factor alpha | TNF | FW: GAGGCCAAGCCCTGGTATG | |
| RV: CGGGCCGATTGATCTCAGC | |||
| Interleukin 6 | IL6 | FW: ACTCACCTCTTCAGAACGAATTG | |
| RV: GTCGAGGATGTACCGAATTTGT | |||
| Cluster of differentiation 200 cell surface glycoprotein receptor | CD200R1 | FW: GAGCAATGGCACAGTGACTGTT | |
| RV: GTGGCAGGTCACGGTAGACA | |||
| Mannose receptor c, type 1 | CD206 (MRC-1) | FW: TGGGTTCCTCTCTGGTTTCC | |
| RV: CAACATTTCTGAACAATCCTATCCA | |||
| Cluster of differentiation 163 | CD163 | FW:CACTATGAAGAAGCCAAAATTACCT | |
| RV: AGAGAGAAGTCCGAATCACAGA | |||
| Interleukin 10 | IL10 | FW: GACTTTAAGGGTTACCTGGGTTG | |
| RV: TCACATGCGCCTTGATGTCTG | |||
| Transforming growth factor, beta 1 | TGFB1 | FW: GCAACAATTCCTGGCGATACCTC | |
| RV: AGTTCTTCTCCGTGGAGCTGAAG | |||
| Matrix metalloproteinase 9 | MMP9 | FW: TGGGGGGCAACTCGGC | |
| RV: GGAATGATCTAAGCCCAG | |||
| Nicotinamide adenine dinucleotide phosphate-oxidase 2 | NOX2 | FW: AACTGGGCTGTGAATGAGGG | |
| RV: GCCAGTGCTGACCCAAGAA | |||
| Nuclear factor kappa-light-chain-enhancer of activated B cells | NFκB | FW: AGACCAAGGAGATGGACCTCA | |
| RV: GCATTGGGGGCTTTACTGTC | |||
| Lipase A or cholesterol ester hydrolase | LIPA | FW: TCCTGCTGGAACTTCTGTGC | |
| RV: ACTGCTTCCCCAGTCAAAGG | |||
| Cluster of differentiation 44 | CD44 | FW: TCAGCAAGAATTTGATCGTTCCAG | |
| RV: TTAGAAGCCATCCATAGCACACC | |||
| Cluster of differentiation 47 | CD47 | FW: TGCATGGCCCTCTTCTGATT | |
| RV: AGGGGTTCCTCTACAGCTT | |||
| Signal regulatory protein alpha | SIRPA | FW: TCAAATACCGCCGCTGAGAA | |
| RV: TGTGATATCATTTGTGTCCTGTGT | |||
| Purinergic receptor P2X 7 | P2RX7 | FW: ACAGTGTCTTTGACACCGCA | |
| RV: CCAGGCAGAGACTTCACAGG |
Genes and proteins analyzed via qPCR and Multiplex ELISA.
| Cluster of differentiation 68 | CD68 | Pan-macrophage marker | x | |
| Monocyte chemoattractant protein 1 | MCP-1 | Chemotactic for monocytes/macrophages | x | x |
| Chemokine (C-C motif) receptor 7 | CCR7 | Pro- inflammatory macrophage marker | x | |
| Interferon gamma | IFN-γ | Pro-inflammatory factor, inhibitor of collagen production and cell proliferation | x | |
| Tumor necrosis factor alpha | TNF-α | Pro-inflammatory factor, stimulus for collagen production, inhibitor of elastogenesis | x | x |
| Interleukin 6 | IL-6 | Pro-inflammatory factor | x | x |
| Cell surface glycoprotein receptor 200 | CD200R1 | Anti-inflammatory macrophage marker | x | |
| Mannose receptor c, type 1 | CD206 (MRC-1) | Anti-inflammatory macrophage marker | x | |
| Cluster of differentiation 163 | CD163 | Anti-inflammatory macrophage marker | x | |
| Interleukin 10 | IL-10 | Anti-inflammatory cytokine, inhibitor of collagen production | x | x |
| Interleukin 13 | IL-13 | Anti-inflammatory macrophage marker, stimulus for collagen production | x | |
| Transforming growth factor beta 1 | TGFβ1 | Anti-inflammatory factor; stimulus for collagen formation | x | x |
| Matrix metalloproteinase 9 | MMP-9 | Anti-inflammatory factor involved in extra-cellular breakdown and remodeling | x | x |
| Matrix metalloproteinase 1 | MMP-1 | Extra-cellular breakdown and remodeling, collagenase | x | |
| Metallopeptidase inhibitor 1 | TIMP-1 | Inhibitor of MMP's | x | |
| Platelet derived growth factor- subunit BB | PDGF-BB | Stimulus for collagen formation and cell proliferation | x | |
| Basic fibroblast growth factor | bFGF | Stimulus for collagen formation, promotes scarless healing | x | |
| Connective tissue growth factor | CTGF | Stimulus for collagen formation | x | |
| Elastase | ELA | Elastin breakdown | x | |
| Nicotinamide adenine dinuc-leotide phosphate-oxidase 2 | NOX2 | Contributor of ROS production | x | |
| Nuclear factor kappa-light-chain-enhancer of activated B cells | NFκβ | Involved in cellular responses to oxidative stress and cell survival | x | |
| Lipase A or cholesterol ester hydrolase | LIPA | Lysosomal enzyme | x | |
| Cluster of differentiation 44 | CD44 | Cell adhesion, migration and fusion | x | |
| Cluster of differentiation 47 | CD47 | Cell adhesion, migration and fusion | x | |
| Signal regulatory protein alpha | SIRPA | Cell fusion and phagocytosis | x | |
| Purinergic receptor P2X 7 | P2RX7 | Regulator of caspase activity, cytokine secretion, cell apoptosis and fusion | x |
Fiber alignment, diameter, pore size and width-height ratio, thickness, and surface to volume ratio of the electrospun scaffolds.
| Isotropic | 2.1 ± 0.3 | 2.6 ± 1.3 | 2.1 ± 0.8 | 167 ± 11 | 1.90 |
| 5.7 ± 0.3 | 11.0 ± 6.2 | 5.0 ± 1.9 | 176 ± 16 | 0.70 | |
| Anisotropic | 2.2 ± 0.2 | 2.7 ± 1.5 | 2.1 ± 0.9 | 123 ± 7 | 1.82 |
| 5.7 ± 0.5 | 7.3 ± 3.4 | 5.7 ± 3.7 | 134 ± 7 | 0.70 |
Figure 2Scaffold characteristics. SEM images of the electrospun PCL-BU scaffolds with different fiber diameter and alignment. Scale bars, 50 μm (A). Frequency histograms with fitted Gaussian distributions to visualize the degree of fiber alignment (90° = main axis) (B). Average cauchy stress-stretch curves of the electrospun microarchitectures (n = 2/group, x = circumferential direction of the electrospinning mandrel; y = axial direction of the electrospinning mandrel) (C).
Figure 3Macrophage morphology on different scaffold microarchitectures. Representative SEM images of macrophages cultured for 8 days on the different scaffold microarchitectures. Arrows identify areas of cell clustering. (x = circumferential direction of the electrospinning mandrel; y = axial direction of the electrospinning mandrel) Scale bars, 30 μm (A). Representative confocal images showing the actin cytoskeleton of macrophages cultured up to 8 days on the different scaffold microarchitectures (actin in green; cell nuclei in blue). Scale bars, 50 μm (B). The average cellular infiltration depth (μm) and calculated fiber surface exposure (cm2) per scaffold type (C).
Figure 4Macrophage-driven biomaterial degradation. Representative SEM images of decellularized scaffolds at day 8. Scale bars, 40 μm; x = circumferential direction of the electrospinning mandrel; y = axial direction of the electrospinning mandrel (A). Semi-quantitative scoring of fiber erosion and cleavage seen in each scaffold type in time (B). Oxidative degradation of the different scaffold microarchitectures in terms of malondialdehyde (MDA) presence and expression of the oxidative genes NOX-2 and NFkB (compared to CYC-1) at day 4 (top row) and day 8 (bottom row) (C). Enzymatic degradation of the synthetic scaffolds investigated via esterase assays on both cell supernatant and lysate (1 unit = 1 nmol pNP released from pNPB per minute), and gene expression (compared to CYC-1) of LIPA at both day 4 (top row) and day 8 (bottom row) (D). A dot represents a statistical outlier. *p < 0.05; **p < 0.01; ***p < 0.001, N ≥ 6/group/time point.
Figure 5Gene expression profiles. Relative expression of pro- and anti-inflammatory genes in macrophages cultured up to day 4 and day 8 on scaffolds with different microarchitectures (A). Relative gene expression of cell fusion markers CD44, SIRPA, the P2x7 receptor, and CD47 (B). CYC-1 was selected as the reference gene. *p < 0.05; **p < 0.01. N ≥ 3/group/time point.
Figure 6Protein secretion. Secretion levels of pro- or anti-inflammtory, and ECM-related proteins for macrophages cultured up to day 8 on scaffolds with different microarchitectures. *Values were extrapolated beyond the standard range. N ≥ 3/group/time point.
Figure 7Gene expression profiles in 2D and 3D. Relative expression of pro- and anti-inflammatory genes, ECM-related genes, and genes involved in cell fusion for biochemically stimulated macrophages cultured on polysterene (2D) or on 6 μm fiber Ø isotropic scaffolds (3D) for 4 days. GAPDH was selected as the reference gene. *p < 0.05; **p < 0.01; ***p < 0.001, N ≥ 6/group/time point.
Figure 8Macrophage phenotype-driven biomaterial degradation. Boxplots visualizing MDA production (oxidative stress) of unpolarized macrophages (M0), LPS/IFN-γ stimulated macrophages (M1), IL-4/IL-13 stimulated macrophages (M2a), and IL-10 stimulated macrophages (M2c) cultured up to 4 days on tissue culture treated well plates (“2D”) or on scaffolds with 6 μm Ø isotropic fibers (“3D”) for 4 days and 8 days (A). Enzymatic activity detected in the supernatant and cell lysate of M0, M1, M2a, and M2c macrophages cultured up to day 4 (2D and 3D) and day 8 (3D) (1 unit = 1 nmol pNP released from pNPB per minute) (B). Gene expression (compared to GAPDH) of NOX2, NFκB, and LIPA for M0, M1, M2a, and M2c macrophages cultured on scaffolds with 6 μm Ø isotropic fibers (C). MDA and enzyme activity values are corrected for DNA content. *p < 0.05; **p < 0.01; ***p < 0.001. N ≥ 4/group/time point.